Welcome to Drugdu.com
  • For Buyer
  • For Supplier
  • 中文专栏
media
  • Home
  • Ddu News
  • Newscast
  • Market Reports
  • New study links migraines to increased risk of cardiovascular problems

    © Provided by AFPRelaxNews Migraine sufferers could be at an increased risk of certain heart problems according to new research.New international research has found that migraine sufferers may also have an increased risk of cardiovascular problems including heart attacks, stroke, blood clots, and an irregular heart rate.

    • Source: msn
    • 122
    • February 8, 2018
    cardiovascular migraine Researches
  • The Effects Of Air Pollution On Human Health

    Although it isn’t talked about often, older adults in the United States are turning to drugs and alcohol at an alarming rate. Studies have found that a large population of older Americans are suffering from substance use disorders, and the number is only expected to rise. According to research, the number of Americans aged 50 and older struggling with addiction is expected to nearly double in the coming years, going from 2.8 million to 5.7 million by 2020.

    • Source: msn
    • 143
    • January 24, 2018
    air pollution asthma cardiovascular pneumonia
  • Tudorza reduces exacerbations and demonstrates cardiovascular safety in COPD patients

    AstraZeneca today announced positive top-line results of the Phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 μg, twice-daily), a long-acting muscarinic antagonist (LAMA), in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), with a history of cardiovascular disease and/or significant cardiovascular risk factors.

    • Source: Astrazeneca
    • 125
    • December 8, 2017
    AstraZeneca cardiovascular Clinical Trials COPD
  • Salt raises blood pressure, but our gut bacteria can stop it

    It's a known fact that too much salt can increase blood pressure. But new research brings gut bacteria into the mix, and some good news along with it: probiotics may help to reverse the harmful effects of excessive salt.

    • Source: medicalnewstoday
    • 174
    • November 17, 2017
    blood pressure cardiovascular gut bacteria New Approvals
  • Jardiance is the first and only oral type 2 diabetes medicine approved to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

    New data presented today showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and peripheral artery disease.

    • Source: finance.yahoo
    • 111
    • November 17, 2017
    cardiovascular diabetes Jardiance® peripheral artery disease
  • EU OKs low-dose Xarelto to prevent recurrent VTE

    A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients.

    • Source: Pharmatimes
    • 137
    • November 8, 2017
    cardiovascular New Approvals venous thromboembolism VTE
  • Ddu College–Market Report of Coronary Stents

    Coronary heart disease is a common illness of cardiovascular disease which is treated mainly through medicines, coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). Remarkably, PCI is preferable to both clinicians and patients for its short treatment course, small wound and significant therapeutic effects: doctors can use PCI to open coronary arteries that are narrowed or blocked by the buildup of atherosclerotic plaque without thoracotomy. Today, Ddu is going to share the market report of coronary stent with you.

    • Source: Ddu
    • 226
    • October 27, 2017
    cardiovascular coronary stent Ddu College
  • China’s Cardiovascular Drugs Import and Export Report

    Cardiovascular drugs are medicines used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and strokes, whose therapeutic effects aim to improve cardiac functions, regulate blood flow of heart and change the circulatory system of blood distribution among other things.

    • Source: Ddu
    • 403
    • October 19, 2017
    cardiovascular Market Reports
  • Hormone therapy for prostate cancer increases cardiac risk

    Androgen-deprivation therapy, which is a common treatment for prostate cancer, has been tentatively linked with an increased risk of cardiovascular disease. A new study solidifies these concerns.

    • Source: medicalnewstoday
    • 178
    • October 19, 2017
    cancer cardiovascular prostate Researches
  • Boehringer’s new risk-prediction model will tap patients who could be good Jardiance candidates

    Boehringer Ingelheim has reason to believe its diabetes medication Jardiance can help fend off cardiovascular death, kidney failure and hospitalization for heart failure. And now, it’s developing a model to help predict which patients are best suited for treatment with the therapy.

    • Source: company insights
    • 129
    • September 28, 2017
    cardiovascular Company Insight diabetes kidney
1 2

Go to Page

Trending Topics

Clinical TrialsCompany InsightDdu CollegeDdu NewsExhibitions & ActivitiesMarket ReportsMarket ViewsNew ApprovalsResearches

Hot Tags

ACTDantibodyAppasthmabreast cancercancerCPhIcredit verificationEMAEUFDAinnovationmedical devicepharmaceuticaltherapyWHO

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

  • Ddu’s International Medical Exhibition Attendance Delivering High Results.

    April 9, 2018
  • Medtec China 2018 scale will grow by 10% to feed the rapidly growing needs of the medical device industry in China

    March 8, 2018
  • Ddu Attended Arab Health A Perfect Match for International Trade

    March 2, 2018
  • Gulf Dentex 2018, will be held in October from 20th to 22nd in ADNEC in Abu Dhabi

    March 2, 2018

Market Reportsmore

  • China’s Import and Export Market Report of Contraceptive Drugs

    March 16, 2018
  • Ddu College — China’s Import and Export Report of Peptic Ulcer Drugs

    January 25, 2018
  • China’s Import and Export Report of External Use Otology Drugs

    January 12, 2018
  • Ddu College–China’s Import and Export Market Report of Antiallergic Drugs

    December 1, 2017
  • Customer Services

  • Contact Us
  • Help Center
  • About Us

  • About Drugdu.com
  • Site Map
  • Buy on Drugdu.com

  • Browse Product Categories
  • Sell on Drugdu.com

  • Supplier Memberships
  • Request for Quotation
  • Blogroll

  • ECHEMI
  • VIETNAM MEDI-PHARM EXPO
  • MEDICARE TAIWAN
  • CPhl & P-MEC China
  • IMMEXLS

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.